Glenmark Secures ANDA Approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
Glenmark Pharmaceuticals Ltd. has received final approval from the United States Food and Drug Administration (US FDA) for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2 percent|0.5 percent.
Timolol Maleate Ophthalmic Solution | 18/05/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy